This is a list of chages to the website.
You can Subscribe to our RSS FEED:  ,
which delivers brain tumor news and additions
to the website via RSS.
(Click HERE for
details on RSS.)
Displaying items 1 to 25 of about 3507
Next 25
 |
|
|
|
|
|
|
Website Changes
|
|
|
|
09/03/2010 |
|
Celldex, Pfizer Split Over Brain Tumor Drug
|
|
|
|
|
|
09/03/2010 |
|
Surgeons Use New Tools to Treat Inoperable Brain Tumors
|
|
|
|
|
|
|
08/29/2010 |
|
Accumulation o f CD133-positive glioma cells after high-dose irradiation by Gamma Knife surgery plus external beam radiation.
|
|
|
|
|
|
08/29/2010 |
|
Poor drug distribution as a possible explanation for the results of the PRECISE trial.
|
|
|
|
|
|
|
08/29/2010 |
|
A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma.
|
|
|
|
|
|
08/17/2010 |
|
Added new trial: A Phase II Study of PDGFR Kinase Inhibitor (Tasigna® - nilotinib) in Biomarker-Enriched Recurrent Malignant Gliomas |
|
|
|
|
|
|
08/17/2010 |
|
ImmunoCellular Therapeutics Announces 2010 Second Quarter Results (And reports 100% 1 year survival!)
|
|
|
|
|
|
08/17/2010 |
|
Moores UCSD Cancer Center Brain Tumor Treatment Program Launches Biomarker Clinical Study
|
|
|
|
|
|
|
08/15/2010 |
|
Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases.
|
|
|
|
|
|
08/15/2010 |
|
First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a mu lticenter experience.
|
|
|
|
|
|
|
08/15/2010 |
|
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma.
|
|
|
|
|
|
08/13/2010 |
|
IBTA E News
|
|
|
|
|
|
|
08/12/2010 |
|
Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme.
|
|
|
|
|
|
08/03/2010 |
|
Scientists Develop “Designer Protein,” Opening New Door in Cancer Research
|
|
|
|
|
|
|
08/03/2010 |
|
Long-Term Follow-Up of DCVax®-Treated Brain Cancer Patients Shows 33% of Patients Reached 4-Year Survival and 27% Have Reached or Exceeded 6-Year Survival
|
|
|
|
|
|
07/31/2010 |
|
FAQ:My wife, age 63, was diagnosed with small cell lung cancer, in February, 2010. At that time the cancer had spread to t... |
|
|
|
|
|
|
07/29/2010 |
|
Patients, hospitals wrestle over tumor tissue
|
|
|
|
|
|
07/28/2010 |
|
ImmunoCellular Therapeutics Announces Licensing Agreement with Targepeutics for Worldwide Intellectual Property Rights to Validated Immunotherapy Target
|
|
|
|
|
|
|
07/21/2010 |
|
|
|
|
|
|
|
07/19/2010 |
|
National Brain Tumor Society
Conference for Patients and Families in Dallas-Ft Worth!”
|
|
|
|
|
|
|
07/18/2010 |
|
IBTA E-News July 2010
|
|
|
|
|
|
07/16/2010 |
|
FDA says breast cancer drug did not extend lives
|
|
|
|
|
|
|
07/12/2010 |
|
Electrifying new brain cancer weapon
|
|
|
|
|
|
07/12/2010 |
|
Arsenic shows promise as cancer treatment, Stanford study finds
|
|
|
|
|
|
|
07/10/2010 |
|
A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma.
|
|
|
|
|
|
|
